✦ LIBER ✦

Erratum to: The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

✍ Scribed by Yasumichi Hitoshi; Nan Lin; Donald G. Payan; Vadim Markovtsov

Book ID: 107619004
Publisher: Carden Jennings Publishing
Year: 2010
Tongue: English
Weight: 168 KB
Volume: 91
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0552-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The current status and the future of JAK

The current status and the future of JAK2 inhibitors for the treatment of myeloproliferative diseases

✍ Yasumichi Hitoshi; Nan Lin; Donald G. Payan; Vadim Markovtsov 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 694 KB

561 POSTER Discovery and preclinical cha

561 POSTER Discovery and preclinical characterization of a series of novel JAK2 small molecule inhibitors for the treatment of myeloproliferative diseases

✍ K.A. Jessen; S. Leonard; K. Froning; C. Tang; C. Smith; D. Ellis; S. Sperry; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

The Current Status and Future Developmen

The Current Status and Future Development of CETP Inhibitors

✍ Philip J. Barter 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 95 KB

Zinc supplementation for the treatment o

Zinc supplementation for the treatment or prevention of disease: Current status and future perspectives

✍ Hajo Haase; Silke Overbeck; Lothar Rink 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 242 KB

[Annual Reports in Medicinal Chemistry]

[Annual Reports in Medicinal Chemistry] Volume 45 || Janus Kinase 2 (JAK2) Inhibitors for the Treatment of Myeloproliferative Neoplasm (MPN)

✍ Purandare, Ashok V. 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 335 KB

The use of mesenchymal (skeletal) stem c

The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives

✍ Basem M. Abdallah; Moustapha Kassem 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Abstract Human bone marrow derived‐mesenchymal (skeletal) stem (MSC) cells are a group of non‐hematopoietic stem cells residing in the perivascular niches in bone marrow. These cells have the capacity to differentiate mainly into mesoderm‐type cells such as osteoblasts, chondrocytes and adipocyt